This study aimed to investigate the clinical value of reduced field-of-view (rFOV) sagittal delayed enhanced MRI in diagnosing of breast tumor. we assessed two groups with and without rFOV sagittal delayed enhanced scanning with a time interval of at least six months.In our study, the detection rate, specificity and positive predictive value of the test group with rFOV were significantly higher than that of the control group without rFOV. rFOV sagittal delayed enhanced scanning indicated clinical value in detecting and differential diagnosis of benign and malignant breast tumors.
This abstract and the presentation materials are available to members only; a login is required.